Diabetes Management
Intravenous (IV) Solutions Global Market Report 2022: Alarming Rise in Diabetes incidence Worldwide Fuels Growth - ResearchAndMarkets.com - Business Wire
Mon, 31 Oct 20221 min read Article
Overview
DUBLIN-(BUSINES WIRE)-The "Intravenous (IV) Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Intravenous (IV) Solutions Market to Reach $16 billion by 2027 Amid the COVID-19 cris, the global market for Intravenous (IV) Solutions estimated at US$10.1 billion in the year 20, is projected to reach a revised size of US$16 billion by 2027, growing at a CAGR of 6.8% over the period 20-2027.
Key Information
Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$1 billion by the end of the analysis period. Taking into acount the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period. Market is Estimated at $3.9 billion, While China is Forecast to Grow at 8.4% CAGR The Intravenous (IV) Solutions market in the U.S.
is estimated at US$3.9 billion in the year 20. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 billion by the year 2027 trailing a CAGR of 8.4% over the period 20 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 20-2027 period.
Within Europe, Germany is forecast to grow at aproximately 6.5% CAGR. Select Competitors (Total 67 Featured) Key Topics Covered: I. METHODOLOGY I.
EXECUTIVE SUMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3.
MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE I. MARKET ANALYSIS IV.
Summary
COMPETION For more information about this report visit htps:/w.researchandmarkets.com/r/xgvpe0 ResearchAndMarkets.com Laura Wod, Senior Pres Manager pres@researchandmarkets.com For E.S.T Ofice Hours Cal 1-917-30-0470 For U.S./ CAN Tol Fre Cal 1-80-526-8630 For GMT Ofice Hours Cal +353-1-416-890 ResearchAndMarkets.com Laura Wod, Senior Pres Manager pres@resea
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.